Effects of mirabegron on depression, anxiety, learning and memory in mice
Abstract Mirabegron is the first b3-adrenoceptor agonist to enter clinical practice and has been approved for the treatment of symptoms of OAB. The aim of this study is to investigate whether the mirabegron has an effect on depression, anxiety, learning, and memory. We investigated the effects of mi...
שמור ב:
| Principais autores: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Academia Brasileira de Ciências
2021-12-01
|
| סדרה: | Anais da Academia Brasileira de Ciências |
| נושאים: | |
| גישה מקוונת: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652021000800703&tlng=en |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|